Abbott Laboratories Share Price (NYSE: ABT)

$132.69

▲

1.32

(1%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Abbott Laboratories Stock chart to analyse performance

Abbott Laboratories stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$131.24
Today's High:$132.77
$132.69
1.09%
Downside
Day's Volatility :1.15%
Upside
0.06%
52 Weeks Low:$110.86
52 Weeks High:$141.23
$132.69
16.45%
Downside
52 Weeks Volatility :21.5%
Upside
6.05%

Abbott Laboratories Stock Returns

Period	Abbott Laboratories	Sector (Health Care)	S&P500
3 Months	-0.79%	3.6%	9.3%
6 Months	-3.58%	-7.7%	8.5%
1 Year	15.7%	-12.6%	14.4%
3 Years	29.16%	8.4%	62.9%

Abbott Laboratories Key Stats

Check Abbott Laboratories key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$131.37
Open	$131.99
Today's High	$132.77
Today's Low	$131.24
Market Capitalization	$230.9B
Today's Volume	$4.4M
52 Week High	$141.23
52 Week Low	$110.86
Revenue TTM	$43.1B
EBITDA	$11.5B
Earnings Per Share (EPS)	$7.97
PE Ratio	16.64
Dividend Yield	1.77%
Profit Margin	32.43%
Quarterly Earnings Growth YOY	0.37%
Return On Equity TTM	30.93%

Stock Returns calculator for Abbott Laboratories Stock including INR - Dollar returns

The Abbott Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Abbott Laboratories investment value today

Current value as on today

₹1,20,844

Returns

₹20,844

(+20.84%)

Returns from Abbott Laboratories Stock

₹15,725 (+15.72%)

Dollar Returns*

₹5,119 (+5.12%)

Indian investors sentiment towards Abbott Laboratories Stock

-52.14%

Period: Aug 2, 2025 to Sep 1, 2025. Change in 30 Days versus previous period

Investment in Abbott Laboratories Shares from India has dropped by -52.14% over the past 30 days, indicating reduced transactional activity.

-30%

Period: Aug 2, 2025 to Sep 1, 2025. Change in 30 Days versus previous period

Search interest for Abbott Laboratories Stock from India on INDmoney has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Abbott Laboratories Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	14064	-13.64	0.41%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	2735	0.00	1.83%
DSP Healthcare Fund Direct Growth	31600	583.97	1.09%

Global Institutional Holdings in Abbott Laboratories

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
9.93%
BlackRock Inc
7.87%
State Street Corp
4.46%
Capital Research & Mgmt Co - Division 3
3.46%
Capital Research Global Investors
2.40%
JPMorgan Chase & Co
2.29%

Analyst Recommendation on Abbott Laboratories Stock

Rating

Trend

Buy

75%Buy

24%Hold

0%Sell

Based on 29 Wall street analysts offering stock ratings for Abbott Laboratories(by analysts ranked 0 to 5 stars)

Abbott Laboratories Share Price Target

What analysts predicted

Upside of 7.38%

Target:

$142.48

Current:

$132.69

Abbott Laboratories share price target is $142.48, a slight Upside of 7.38% compared to current price of $132.69 as per analysts' prediction.

Abbott Laboratories Stock Insights

Price Movement
In the last 3 months, ABT stock has moved down by -0.7%
Increasing Revenue
Abbott Laboratories has shown positive revenue growth over the last two quarters. The company's revenue increased from $10.35 billion to $11.14 billion, reflecting an average growth rate of 7.0% per quarter.
Increasing Net Profit
Abbott Laboratories has shown strong profit growth over the last two quarters. In the first quarter, their net profit was $1.32 billion, and it increased to $1.77 billion in the second quarter. This represents an average increase of 25.5% in profit per quarter.

Abbott Laboratories Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$31.9B	↑ 4.34%
Net Income	$3.7B	↑ 55.7%
Net Profit Margin	11.56%	↑ 3.82%

	FY20	Y/Y Change
Revenue	$34.6B	↑ 8.48%
Net Income	$4.5B	↑ 21.91%
Net Profit Margin	12.99%	↑ 1.43%

	FY21	Y/Y Change
Revenue	$43.1B	↑ 24.47%
Net Income	$7.1B	↑ 57.31%
Net Profit Margin	16.42%	↑ 3.43%

	FY22	Y/Y Change
Revenue	$43.7B	↑ 1.34%
Net Income	$6.9B	↓ 1.95%
Net Profit Margin	15.88%	↓ 0.54%

	FY23	Y/Y Change
Revenue	$40.1B	↓ 8.12%
Net Income	$5.7B	↓ 17.45%
Net Profit Margin	14.27%	↓ 1.61%

	FY24	Y/Y Change
Revenue	$42.0B	↑ 4.59%
Net Income	$13.4B	↑ 134.18%
Net Profit Margin	31.95%	↑ 17.68%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$10.0B	↓ 2.7%
Net Income	$1.2B	↓ 23.15%
Net Profit Margin	12.29%	↓ 3.27%

	Q2 FY24	Q/Q Change
Revenue	$10.4B	↑ 4.14%
Net Income	$1.3B	↑ 6.29%
Net Profit Margin	12.55%	↑ 0.26%

	Q3 FY24	Q/Q Change
Revenue	$10.6B	↑ 2.49%
Net Income	$1.6B	↑ 26.42%
Net Profit Margin	15.48%	↑ 2.93%

	Q4 FY24	Q/Q Change
Revenue	$11.0B	↑ 3.19%
Net Income	$9.2B	↑ 460.69%
Net Profit Margin	84.1%	↑ 68.62%

	Q1 FY25	Q/Q Change
Revenue	$10.4B	↓ 5.61%
Net Income	$1.3B	↓ 85.64%
Net Profit Margin	12.79%	↓ 71.31%

	Q2 FY25	Q/Q Change
Revenue	$11.1B	↑ 7.57%
Net Income	$1.8B	↑ 34.26%
Net Profit Margin	15.97%	↑ 3.18%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$16.7B	↑ 5.5%

	FY20	Y/Y Change
Profit	$17.4B	↑ 4.1%

	FY21	Y/Y Change
Profit	$23.2B	↑ 33.59%

	FY22	Y/Y Change
Profit	$22.3B	↓ 3.84%

	FY23	Y/Y Change
Profit	$20.0B	↓ 10.24%

	FY24	Y/Y Change
Profit	$21.3B	↑ 6.43%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$5.0B	↓ 4.49%

	Q2 FY24	Q/Q Change
Profit	$5.3B	↑ 5.64%

	Q3 FY24	Q/Q Change
Profit	$5.4B	↑ 2.28%

	Q4 FY24	Q/Q Change
Profit	$5.6B	↑ 3.17%

	Q1 FY25	Q/Q Change
Profit	$5.4B	↓ 2.75%

	Q2 FY25	Q/Q Change
Profit	$6.3B	↑ 16.53%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$6.1B	↓ 2.6%
Investing Cash Flow	$-1.8B	↑ 33.85%
Financing Cash Flow	$-4.3B	↓ 58.72%

	FY20	Y/Y Change
Operating Cash Flow	$7.9B	↑ 28.76%
Investing Cash Flow	$-2.2B	↑ 22.04%
Financing Cash Flow	$-2.8B	↓ 35.21%

	FY21	Y/Y Change
Operating Cash Flow	$10.5B	↑ 33.31%
Investing Cash Flow	$-2.0B	↓ 9.35%
Financing Cash Flow	$-5.5B	↑ 97.7%

	FY22	Y/Y Change
Operating Cash Flow	$9.6B	↓ 9.04%
Investing Cash Flow	$-1.7B	↓ 13.35%
Financing Cash Flow	$-7.6B	↑ 38.99%

	FY23	Y/Y Change
Operating Cash Flow	$7.3B	↓ 24.21%
Investing Cash Flow	$-3.1B	↑ 80.06%
Financing Cash Flow	$-7.1B	↓ 7.14%

	FY24	Y/Y Change
Operating Cash Flow	$8.6B	↑ 17.86%
Investing Cash Flow	$-2.3B	↓ 25.38%
Financing Cash Flow	$-5.4B	↓ 23.79%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$1.0B	↓ 66.26%
Investing Cash Flow	$-425.0M	↓ 48.42%
Financing Cash Flow	$-1.2B	↓ 42.69%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$2.0B	↑ 91.22%
Investing Cash Flow	$-453.0M	↑ 6.59%
Financing Cash Flow	$-791.0M	↓ 32.74%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$2.7B	↑ 38.01%
Investing Cash Flow	$-594.0M	↑ 31.13%
Financing Cash Flow	$-1.6B	↑ 99.24%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$2.9B	↑ 6.03%
Investing Cash Flow	$-866.0M	↑ 45.79%
Financing Cash Flow	$-1.9B	↑ 18.08%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$1.4B	↓ 50.59%
Investing Cash Flow	$-470.0M	↓ 45.73%
Financing Cash Flow	$-2.1B	↑ 10.42%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$3.5B	↑ 144.46%
Investing Cash Flow	$-1.1B	↑ 123.83%
Financing Cash Flow	$-3.2B	↑ 53.38%

Abbott Laboratories Technicals Summary

Sell

Neutral

Buy

Abbott Laboratories is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Abbott Laboratories Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Abbott Laboratories	2.1%	-3.58%	15.7%	29.16%	25.71%
Johnson & Johnson	3.58%	7.1%	5.99%	8.57%	18.47%
Pfizer Inc.	5.23%	-3.84%	-12.51%	-45.89%	-31.98%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05
Johnson & Johnson	18.97	18.97	1.08	10.85	0.3	0.08	0.03	32.6
Pfizer Inc.	13.1	13.1	0.84	3.07	0.12	0.05	0.07	15.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Abbott Laboratories	Buy	$230.9B	25.71%	16.64	32.43%
Johnson & Johnson	Buy	$426.7B	18.47%	18.97	25.0%
Pfizer Inc.	Hold	$140.8B	-31.98%	13.1	16.84%

Abbott Laboratories Dividend announcements

Abbott Laboratories Dividends September, 2025
In the quarter ending September,2025. Abbott Laboratories has declared dividend of $0.59

About Abbott Laboratories

Abbott Laboratories, headquartered in Chicago, Illinois, was founded in 1888 by a physician named Dr Wallace Calvin. His purpose was to improve people's well-being and help them reach their full potential at different stages of their lives. Founded as a drug formulation company, today, Abbott Laboratories is a worldwide leader in healthcare, medical devices, nutritional products, and pharmaceutical drugs. Even though it reached the shores of India a century ago, it is still regarded as one of the largest healthcare product companies. With a focus on cardiovascular, diagnostic, diabetes, and neuromodulation products, some of its popular brands include Pedialyte, Glucerna, Similac, Ensure, and iStat. Abbott opened its first international office in London in 1907, and currently operates in over 160 countries. Its growth is also a result of strategic acquisitions. Abbott’s recent acquisitions include Kalo Pharma International in 2014, which doubled its brand generic drug portfolio. It acquired Tendyne in 2015 and along with it the company’s minimally invasive mitral valve replacement therapies. Another gem in the crown is the acquisition of Alere in 2016, which gave Abbott access to the largest mail-order diabetic supplier, Arriva Medical. Along with strategic acquisitions, the company is dedicated to gaining a strong competitive advantage. With the onset of COVID-19, the company has developed various antibody tests that have been granted emergency-use authorization. According to Forbes, Abbott Laboratories' fast and low-cost testing methods have expedited the detection of COVID-19 virus. For its 2030 sustainability plan, the company is gearing up to introduce revolutionary products such as BinaxNOW, a COVID-19 test, and FreeStyle Libre, an innovative glucose monitoring device. Abbott’s future plans are centred around providing cutting-edge technologies at affordable prices to even the most vulnerable sections of society. Currently Abbott Laboratories has a market cap of $196.19 Billion. It has a P.E ratio of 35.31. The shares of Abbott Laboratories are trading at $132.69. .

Organization	Abbott Laboratories
Employees	114000
CEO	Mr. Robert B. Ford
Industry	Health Technology

Key Management of Abbott Laboratories

Name	Title
Mr. Robert B. Ford	Chairman of the Board, President & CEO
Mr. Philip P. Boudreau	CFO & Executive VP of Finance
Mr. Daniel Gesua Sive Salvadori	Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
Ms. Lisa D. Earnhardt	Executive VP & Group President of Medical Devices
Ms. Sabina Ewing	Senior VP of Business & Technology Services and Chief Information Officer
Mr. Michael Comilla	Vice President of Investor Relations.
Erica L. Battaglia	VP and Chief Ethics & Compliance Officer
Ms. Elizabeth Cushman	Executive VP, General Counsel & Secretary
Ms. Mary K. Moreland	Executive Vice President of Human Resources
Ms. Melissa Brotz	Senior Vice President of Global Marketing & External Affairs

Important FAQs about investing in ABT Stock from India :

What is Abbott Laboratories share price today?

Abbott Laboratories share price today is $132.69 as on August 30, 2025 at 1:29 am IST at the close of the market. Abbott Laboratories share today touched a day high of $132.77 and a low of $131.24.

What is the 52 week high and 52 week low for Abbott Laboratories share?

Abbott Laboratories share touched a 52 week high of $141.23 and a 52 week low of $110.86. Abbott Laboratories stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $132.69, lower by 6.05% versus the 52 week high.

How to invest in Abbott Laboratories Stock (ABT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Abbott Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbott Laboratories Shares that will get you 0.0113 shares as per Abbott Laboratories share price of $132.69 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Abbott Laboratories Stock (ABT) from India?

Indian investors can start investing in Abbott Laboratories (ABT) shares with as little as ₹88.1475 or $1 (as of September 02, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.47 in Abbott Laboratories stock (as per the Rupee-Dollar exchange rate as on September 02, 2025). Based on Abbott Laboratories share’s latest price of $132.69 as on August 30, 2025 at 1:29 am IST, you will get 0.0754 shares of Abbott Laboratories. Learn more about fractional shares .

What are the returns that Abbott Laboratories has given to Indian investors in the last 5 years?

Abbott Laboratories stock has given 25.71% share price returns and 20.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?